Workflow
VRTX Q3 Earnings & Sales Trump Estimates, '24 Sales View Raised
VRTXVertex(VRTX) ZACKS·2024-11-05 17:26

Vertex Pharmaceuticals Incorporated (VRTX) reported adjusted earnings of 4.38pershareforthethirdquarterof2024,surpassingtheZacksConsensusEstimateof4.38 per share for the third quarter of 2024, surpassing the Zacks Consensus Estimate of 4.13. In the year-ago quarter, the company had recorded adjusted earnings of 4.08pershare.Earningsgrewyearoveryearowingtoincreasedproductrevenues.Thecompanyreportedtotalrevenuesof4.08 per share. Earnings grew year over year owing to increased product revenues.The company reported total revenues of 2.77 billion for the third quarter, comprising cystic fibrosis (CF) product revenues. The figure beat the Zacks Consensus Estimate of $2.67 billion. ...